The top two are for scolds.
Point is Avita now have a product they can market and as the public become aware that ReCell is gold standard FDA approved care enrollment should be a lot faster.
Venous leg ulcers is a mega care market.
Well done Bread,
MB
Ongoing clinical trials, page-2
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.49 |
Change
0.020(0.81%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| $2.47 | $2.49 | $2.47 | $35.95K | 14.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1799 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.49 | 10882 | 7 |
View Market Depth
| Last trade - 10.11am 11/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |